Top Markets
Coin of the day
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.

AXIM Biotechnologies, Inc.

AXIM
Rang în acțiuni #37613
AXIM Biotechnologies, Inc. specializes in the creation and distribution of... AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.
Preț acțiune
$0.0046
Ultima sincronizare: 2026-08-14
Capitalizare de piață
$1.57M
Schimbare (1 zi)
-8.00%
Schimbare (1 an)
-9.80%
Țară
US
Tranzacționează AXIM Biotechnologies, Inc. (AXIM)

Categorie

Venituri pentru AXIM Biotechnologies, Inc. (AXIM)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale AXIM Biotechnologies, Inc., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru AXIM Biotechnologies, Inc. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
$12.62B -
US
$6.02B -
NL
- -
CH
- -
KR
$10.11B -
BE